[Form 4] Health In Tech, Inc. Insider Trading Activity

Rhea-AI Filing Summary

LinLin Qian, who serves as Chief Financial Officer, a director and a >10% owner of Health In Tech, Inc. (HIT), received a grant of 80,000 restricted shares of Class A Common Stock on 09/24/2025 at a reported price of $0. Following the grant, the reporting person beneficially owns 8,128,555 shares, which the filing states includes 130,495 restricted shares and 7,998,060 Class A shares (the filing separately excludes 2,700,000 Class B shares and 711,510 options). The restricted shares vest in three equal tranches tied to an initiative: monthly over 12 months after a letter of intent, monthly over 12 months after proof-of-concept or beta launch, and monthly over 12 months after full commercial launch.

Positive

• Structured vesting tied to milestones aligns the reporting person's incentives with company project progress
• Grant reported as restricted stock under the company's Equity Incentive Plan, indicating formal compensation governance

Negative

• None.

Insights

Securities Analyst

TL;DR Insider received 80,000 restricted Class A shares, increasing reported beneficial ownership to 8.13 million shares.

The transaction is a structured equity grant rather than an open-market purchase and is priced at $0, indicating restricted stock issued as compensation under the company equity plan. Vesting is milestone-based with three 12-month monthly installment tranches tied to initiative milestones, which aligns the recipient's compensation with project progress. The grant increases reported beneficial ownership but the filing also discloses substantial holdings excluded from the Class A total (Class B shares and options), which affect overall capitalization and control dynamics. Impact on outstanding share count and immediate market dilution is not quantified in the filing.

Corporate Governance Expert

TL;DR Grant reflects compensation and retention mechanism with milestone-driven vesting; disclosure is clear on vesting triggers and holdings.

The Form 4 documents a standard restricted stock award under the Health In Tech Equity Incentive Plan with explicit vesting triggers tied to company initiatives, which is consistent with retention and performance alignment practices. The reporting person is identified as CFO, director and >10% owner, and the filing separates Class A, Class B and option holdings to clarify beneficial ownership. The filing does not provide details on the total shares outstanding or percentage ownership post-grant, limiting assessment of governance control shifts from this single filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Qian LinLin

(Last) (First) (Middle)

701 S. COLORADO AVE,

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/24/2025		A		80,000(1)	A	$0	8,128,555(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

2. Includes 130,495 shares of restricted stock and 7,998,060 shares of Class A Common Stock. Excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase shares of Class A Common Stock.

	/s/ LinLin Qian	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for HIT and what are their roles?

The Form 4 was filed by LinLin Qian, who is listed as the company's Chief Financial Officer, a director, and a >10% owner.

What transaction was reported on the HIT Form 4 dated 09/24/2025?

The filing reports a grant of 80,000 restricted shares of Class A Common Stock to the reporting person on 09/24/2025 at a reported price of $0.

How many shares does the reporting person beneficially own after the transaction?

Following the grant, the reporting person beneficially owns 8,128,555 shares, which the filing states includes 130,495 restricted shares and 7,998,060 Class A shares.

What is the vesting schedule for the restricted shares?

Vesting is in three equal parts: one third vests monthly over 12 months after a letter of intent for an initiative, one third vests monthly over 12 months after proof-of-concept or beta launch, and one third vests monthly over 12 months after full commercial launch.

Does the filing disclose other securities held by the reporting person?

Yes. The filing excludes 2,700,000 shares of Class B Common Stock and 711,510 options to purchase Class A Common Stock from the 8,128,555 figure.